Evidence map›Paper›PMID 36361524›Full record

ArticleInternational journal of molecular sciences2022

Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein.

Te-Hsien Lin, Kuo-Hsuan Chang, Ya-Jen Chiu, Zheng-Kui Weng, Ying-Chieh Sun, Wenwei Lin, Guey-Jen Lee-Chen, Chiung-Mei Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Neurotrophic Effects ofInternational journal of molecular sciences · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Coumarin: A natural solution for alleviating inflammatory disorders.Current research in pharmacology and drug discovery · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Using ΔK280 TauBiomolecules · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Te-Hsien LinDepartment of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.
Kuo-Hsuan ChangDepartment of Neurology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.ORCID 0000-0003-4972-9823
Ya-Jen ChiuDepartment of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.ORCID 0000-0003-3195-2509
Zheng-Kui WengDepartment of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.
Ying-Chieh SunDepartment of Chemistry, National Taiwan Normal University, Taipei 11677, Taiwan.
Wenwei LinDepartment of Chemistry, National Taiwan Normal University, Taipei 11677, Taiwan.
Guey-Jen Lee-ChenDepartment of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.ORCID 0000-0003-4818-9917
Chiung-Mei ChenDepartment of Neurology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.ORCID 0000-0002-0769-0353
National Taiwan Normal University · TWChang Gung University · TW

Funding

Ministry of Science and Technology, Taiwan 109-2320-B-003-008Ministry of Science and Technology, Taiwan 109-2320-B-182A-021Ministry of Science and Technology, Taiwan 109-2811-B-003-503
6 · The paper itself

Abstract

Hyperphosphorylation and aggregation of the microtubule binding protein tau is a neuropathological hallmark of Alzheimer's disease/tauopathies. Tau neurotoxicity provokes alterations in brain-derived neurotrophic factor (BDNF)/tropomycin receptor kinase B (TRKB)/cAMP-response-element binding protein (CREB) signaling to contribute to neurodegeneration. Compounds activating TRKB may therefore provide beneficial effects in tauopathies. LM-031, a coumarin derivative, has demonstrated the potential to improve BDNF signaling in neuronal cells expressing pro-aggregated ΔK280 tau mutant. In this study, we investigated if LM-031 analogous compounds provide neuroprotection effects through interaction with TRKB in SH-SY5Y cells expressing ΔK280 tau

Indexed as

Alzheimer DiseaseNeuroblastomaNeuroprotective AgentsTauopathiesBrain-Derived Neurotrophic FactorCaspasesCoumarinsCyclic AMP Response Element-Binding ProteinHumansNeuroprotectionPhosphatidylinositol 3-KinasesReceptor, trkBtau ProteinsBrain-Derived Neurotrophic FactorCaspasesCoumarinsCyclic AMP Response Element-Binding ProteinNeuroprotective AgentsPhosphatidylinositol 3-KinasesReceptor, trkBtau Proteinsneuroprotectionpro-aggregated tautauopathiestherapeuticsTRKB signaling

Identifiers

PMID36361524
PMCPMC9654711
OpenAlexW4307273182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.